Skip to content

FGFR2(IIIb), AlpHcAbs® Human Alpaca Monoclonal Antibody

Usd: 700

Specification

Bulk Order Quote | Customization Request

Catalog# HA710328

FGFR2(IIIb), AlpHcAbs® Human Alpaca Monoclonal Antibody

Application

  • ELISA

  • FC

Reactivity

  • Human

Conjugation

  • unconjugated

Overview

Product Name

FGFR2(IIIb), AlpHcAbs® Human Alpaca Monoclonal Antibody

Antibody Type

Alpaca Nanobody

Immunogen

Recombinant human FGFR2(IIIb)

Product Specificity

Human FGFR2(IIIb)

Species Reactivity

Human

Validated Applications

ELISA, FC

Conjugation

unconjugated

Product Features

Form

Liquid

Concentration

Storage Instructions

Store at –20 ℃, (Avoid freeze / thaw cycles), Stable for 12 months at -20℃

Storage Buffer

Liquid, 10mM PBS (pH 7.5), 0.05% sucrose, 0.1% trehalose, 0.01% proclin300, 50% Glycerol

Isotype

VHH domain of alpaca IgG2b/2c fused to Human IgG1 Fc(mutation)

Purification Method

Immunogen affinity purified.

Application Dilution

  • ELISA

  • 1:4,000-1:10,000

  • FC

  • 1:200-1:1,000

Target

Function

Anti-FGFR2(IIIb), AlpHcAbs® Human antibody is designed for detecting human FGFR2(IIIb) specifically. Anti-FGFR2(IIIb), AlpHcAbs® Human antibody is recombinant VHH domain of alpaca IgG2b/2c fused to Human IgG1 Fc. Based on ELISA, Anti-FGFR2(IIIb), AlpHcAbs® Human antibody reacts with human FGFR2(IIIb), and has reactivity with cynomolgus FGFR2(IIIb).

Background References

暂无

Subcellular Location

Cell membrane, Golgi apparatus, Cytoplasmic vesicle

UNIPROT

SwissProt: P21802 Human

Synonyms

bacteria-expressed kinase antibody

BBDS antibody

BEK antibody

BEK fibroblast growth factor receptor antibody

BFR1 antibody

CD332 antibody

CD332 antigen antibody

CEK3 antibody

CFD1 antibody

Craniofacial dysostosis 1 antibody

Expand

Images

  • Advantages of using an Alpaca Recombinant Secondary<br />1. Smaller size<br />Nanobodies are 1/10 the size of a traditional antibody (~15 kDa unconjugated). This means that the nanobody can penetrate tissue faster and deeper than other antibodies.<br />2. Easier to use<br />Due to their simple structure, nanobodies also have the advantage of increased stability and ease of use. <br />3. Easier production<br />When compared to a more traditional antibody, nanobodies are easier to develop and produce in the lab than monoclonal or polyclonal antibodies. <br />4. More consistent<br />Since nanobodies are recombinantly produced from clonal DNA, you are guaranteed the same product every time. Comparatively, polyclonal antibodies are produced in live animals and have a very low lot-to-lot consistency while monoclonal antibodies can suffer from drift.<br />5. Higher Affinity<br />Nanobodies benefit from consistently high binding affinity values.

    Advantages of using an Alpaca Recombinant Secondary
    1. Smaller size
    Nanobodies are 1/10 the size of a traditional antibody (~15 kDa unconjugated). This means that the nanobody can penetrate tissue faster and deeper than other antibodies.
    2. Easier to use
    Due to their simple structure, nanobodies also have the advantage of increased stability and ease of use.
    3. Easier production
    When compared to a more traditional antibody, nanobodies are easier to develop and produce in the lab than monoclonal or polyclonal antibodies.
    4. More consistent
    Since nanobodies are recombinantly produced from clonal DNA, you are guaranteed the same product every time. Comparatively, polyclonal antibodies are produced in live animals and have a very low lot-to-lot consistency while monoclonal antibodies can suffer from drift.
    5. Higher Affinity
    Nanobodies benefit from consistently high binding affinity values.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"